This is a guest blog by Bas ter Braak, currently a PhD candidate at the Leiden Academic Center for Drug Research, and co-author on an article published in… Read more »
Bas ter Braak is a PhD candidate at the Leiden Academic Centre for Drug Research (LACDR), which is part of the Leiden University. Within the cancer research field he is studying the mitogenic and carcinogenic potential of growth factors.
Latest posts by Bas ter Braak (see all)
- Anti-diabetic insulin analogue drugs and breast cancer development - 27th February 2015